Skip to main content

Table 3 Radiation-absorbed dose estimates for [18F]-tetrafluoroborate based on whole-body imaging in non-human primates

From: Radiation dosimetry and biodistribution in non-human primates of the sodium/iodide PET ligand [18F]-tetrafluoroborate

Target organ Dose (mGy/MBq)
  Mean SD
Adrenals 1.44E−02 7.1E−05
Brain 4.54E−03 5.3E−04
Breasts 9.52E−03 2.8E−04
Gallbladder wall 1.46E−02 7.1E−05
LLI wall 1.42E−02 1.4E−04
Small intestine 1.43E−02 0.0E+00
Stomach wall 7.86E−02 1.9E−02
ULI wall 1.42E−02 0.0E+00
Heart wall 1.77E−02 7.1E−04
Kidneys 2.25E−02 3.5E−04
Liver 1.27E−02 2.8E−04
Lungs 1.78E−02 2.1E−03
Muscle 1.14E−02 2.1E−04
Ovaries 1.44E−02 0.0E+00
Pancreas 1.85E−02 1.1E−03
Red marrow 1.66E−02 1.4E−04
Osteogenic cells 2.01E−02 4.9E−04
Skin 8.68E−03 2.1E−04
Spleen 1.42E−02 7.8E−04
Testes 1.12E−02 7.1E−05
Thymus 1.18E−02 3.5E−04
Thyroid 4.23E−02 2.1E−04
Urinary bladder wall 4.79E−02 1.5E−02
Uterus 1.56E−02 5.7E−04
Parotid glanda 4.13E−02 2.1E−02
Submandibular glanda 2.74E−02 1.7E−02
Total body 1.18E−02 1.4E−04
Effective dose equivalent (mSv/MBq) 2.21E−02 1.8E−03
Effective dose (mSv/MBq) 2.47E−02 2.8E−03
  1. aAbsorbed dose calculated using the sphere model